Dystrophy, landouzy-dejerine

Clinical trials for Dystrophy, landouzy-dejerine explained in plain language.

Never miss a new study

Get alerted when new Dystrophy, landouzy-dejerine trials appear

Sign up with your email to follow new studies for Dystrophy, landouzy-dejerine, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1

New hope for FSHD: Long-Term drug safety trial underway

Disease control Ongoing

This study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …

Matched conditions: DYSTROPHY, LANDOUZY-DEJERINE

Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

Dystrophy, landouzy-dejerine

Get alerted when new Dystrophy, landouzy-dejerine trials appear

New hope for FSHD: Long-Term drug safety trial underway